North Growth Management Ltd. Amgen Inc Transaction History

North Growth Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $5.77 Million - $6.42 Million	-25,000 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $4.39 Million - $4.85 Million	-20,000 Reduced 44.44%	25,000 $6.14 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $865,520 - $1.03 Million	-4,000 Reduced 8.16%	45,000 $10.4 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $791,240 - $970,960	-4,000 Reduced 7.55%	49,000 $11.5 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $1.46 Million - $1.93 Million	-8,000 Reduced 13.11%	53,000 $10.8 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $174,110 - $208,620	1,000 Added 1.67%	61,000 $11.7 Million
Q4 2017 Aug 10, 2018	BUY	$168.79 - $188.59 $10.1 Million - $11.3 Million	60,000	60,000 $10.5 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of North Growth Management Ltd., based on Form 13F filings with the SEC.

Stay updated on North Growth Management Ltd. with notifications on news.